These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29878660)
1. Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes. Pierce GF; Iorio A Haemophilia; 2018 May; 24 Suppl 6():60-67. PubMed ID: 29878660 [TBL] [Abstract][Full Text] [Related]
3. What´s new in Gene Therapy of Hemophilia. Rodriguez-Merchan EC Curr Gene Ther; 2018; 18(2):107-114. PubMed ID: 29446741 [TBL] [Abstract][Full Text] [Related]
4. Haemophilia gene therapy: From trailblazer to gamechanger. Evens H; Chuah MK; VandenDriessche T Haemophilia; 2018 May; 24 Suppl 6():50-59. PubMed ID: 29878653 [TBL] [Abstract][Full Text] [Related]
5. Current and emerging gene therapies for haemophilia A and B. Kaczmarek R; Miesbach W; Ozelo MC; Chowdary P Haemophilia; 2024 Apr; 30 Suppl 3():12-20. PubMed ID: 38528615 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia. Björkman S; Berntorp E Clin Pharmacokinet; 2001; 40(11):815-32. PubMed ID: 11735604 [TBL] [Abstract][Full Text] [Related]
7. Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia. Peyvandi F; Garagiola I Haemophilia; 2019 Sep; 25(5):738-746. PubMed ID: 31282050 [TBL] [Abstract][Full Text] [Related]
8. Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns. Pierce GF Haemophilia; 2021 Feb; 27 Suppl 3():103-113. PubMed ID: 32484283 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice. Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565 [TBL] [Abstract][Full Text] [Related]
10. State of the art: gene therapy of haemophilia. Spencer HT; Riley BE; Doering CB Haemophilia; 2016 Jul; 22 Suppl 5():66-71. PubMed ID: 27405679 [TBL] [Abstract][Full Text] [Related]
11. The critical need for postmarketing surveillance in gene therapy for haemophilia. Konkle BA; Recht M; Hilger A; Marks P Haemophilia; 2021 Feb; 27 Suppl 3():126-131. PubMed ID: 32495492 [TBL] [Abstract][Full Text] [Related]
12. The gene therapy journey for hemophilia: are we there yet? High KA Hematology Am Soc Hematol Educ Program; 2012; 2012():375-81. PubMed ID: 23233607 [TBL] [Abstract][Full Text] [Related]
17. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
18. Factoring nonviral gene therapy into a cure for hemophilia A. Gabrovsky V; Calos MP Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922 [TBL] [Abstract][Full Text] [Related]
19. [Effective gene therapy for hemophilia, at last…]. Jordan B Med Sci (Paris); 2018 Mar; 34(3):267-274. PubMed ID: 29547114 [TBL] [Abstract][Full Text] [Related]
20. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]